Hosted on MSN19d
Seattle firm targets hepatitis B through gene-editingThe new drug uses lipid nanoparticles to deliver a molecule ... What they're saying: A cure for hepatitis B would transform the lives of millions and free future generations from "a virus that ...
Hepatitis C virus (HCV ... Finally, innovative vaccine candidates, such as nanoparticle-based vaccines displaying permuted E1E2 glycoproteins, have shown promise in eliciting robust neutralizing ...
DSPC:Chol:PEG–C–DMA:DLin–DMA (20:48:2:30)–siRNA Hepatitis B virus (yes ... and lower toxicity in comparison with inorganic nanoparticles and viral vectors. Function-engineerable ...
N. Kato, M. Hijikata, Y. Ootsuyama, M. Nakagawa, et al., "Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis," Proceedings of the National ...
Lipoxen joins with Nottingham University to deliver antiviral drugs direct to the liver by means of nanoparticles for the treatment of viral hepatitis. Lipoxen joins with Nottingham University to ...
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results